Healthcare Social Media and Updates

Medical Training Fuels Imposter Syndrome, Not Personal Failure
SocialMar 23, 2026

Medical Training Fuels Imposter Syndrome, Not Personal Failure

The medical system thrives on your imposter syndrome. It is not a personal failing. It is a feature of your training. From medical school onward, physicians are conditioned to view uncertainty as dangerous. We are trained to find exactly how we do...

By Kevin Pho, MD
Calf Size Predicts Lifespan: Bigger Muscles, Longer Life
SocialMar 23, 2026

Calf Size Predicts Lifespan: Bigger Muscles, Longer Life

A simple body measurement may predict how long you live. Calf circumference. Muscle is longevity. h/t hyderabaddoctor

By Robert Lufkin, MD
Solid Data Foundations Outperform Point‑Solution Automation
SocialMar 23, 2026

Solid Data Foundations Outperform Point‑Solution Automation

Before investing in smarter automation… Fix the data foundation. Why infrastructure beats point solutions → https://t.co/qWIUPgZhYD @MadaketHealth #PayerIT #HITSM

By Colin Hung
Fermented Cordyceps Broth Improves Primary Insomnia in Trial
SocialMar 23, 2026

Fermented Cordyceps Broth Improves Primary Insomnia in Trial

Effectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool https://t.co/g5iOuzkctO

By Michael Lustgarten, PhD
Policy Shifts Reflect Learning, Not Failure, Amid New Virus
SocialMar 23, 2026

Policy Shifts Reflect Learning, Not Failure, Amid New Virus

Smart piece by @FenitN about the rewriting of #Covid history. I would add this: A brand new virus meant health officials were making policy based on the info they had at the time, not what we know now. Policy shifts...

By Helen Branswell
US Patients Access Zegfrovy via Apex Oncology
SocialMar 23, 2026

US Patients Access Zegfrovy via Apex Oncology

Another win for Dizal, but how do US patients get hold of Zegfrovy? Via @ApexOnco -> https://t.co/4GVjyHS9vz https://t.co/bjjrnZkNL6

By Jacob Plieth
Dietitians: Powerful Advocates Transforming Patient Care
SocialMar 23, 2026

Dietitians: Powerful Advocates Transforming Patient Care

A decade ago, I used to think "I'm just a dietitian, I'm not a *real* member of the healthcare team that actually matters." Then I realized that I could be the best f*cking advocate my patients had ever had. And that...

By The Well-Minded Plate (RDN)
FTC Launches Healthcare Task Force to Curb Epic’s Dominance
SocialMar 23, 2026

FTC Launches Healthcare Task Force to Curb Epic’s Dominance

This administration let Hewlett Packard Enterprise keep Juniper Networks, settled with Ticketmaster, and let Google keep Chrome. But healthcare keeps being the exception. The Federal Trade Commission's new Healthcare Task Force looks like the beginning of a coordinated enforcement apparatus...

By Brendan Keeler
Cencora Expands Monopoly with $1.1B Retina Acquisition
SocialMar 23, 2026

Cencora Expands Monopoly with $1.1B Retina Acquisition

Another day, another acquisition by drug wholesaler monopolist Cencora. This one is EyeSouth Partners's retina business for $1.1 billion. https://t.co/F6Cj1hXCzy

By Matt Stoller
AI Reliance Undermines Clinician Skill and Accuracy
SocialMar 23, 2026

AI Reliance Undermines Clinician Skill and Accuracy

One of the biggest fears about healthcare's AI revolution is that AI can erode physicians’ expertise and their performance may drop when AI is removed. A new scoping review provides examples for that. In colonoscopy, the adenoma detection rate dropped significantly...

By Bertalan Meskó, PhD
AI Transforming Healthcare: Insights From CBS Mornings Interview
SocialMar 23, 2026

AI Transforming Healthcare: Insights From CBS Mornings Interview

A thrill to be on @CBSMornings today talking AI and Healthcare (and about my book, "A Giant Leap") with @nateburleson & @DrLaPook. Interview is here: https://t.co/YJygJk0qh8

By Robert (Bob) Wachter, MD
Healthcare Still Not a Market, Tech to Deflate Costs
SocialMar 23, 2026

Healthcare Still Not a Market, Tech to Deflate Costs

Is healthcare actually a market? According to Chris Klomp, RFK's No. 2 at HHS, the answer is: Not yet. I sat down with Chris and Jon Gordon to discuss how we turn technology into a "deflationary force" instead of a cost-adder. The...

By Christina Farr
FDA Review and Study Data Lift Insmed Stock
SocialMar 23, 2026

FDA Review and Study Data Lift Insmed Stock

FDA seeks feedback on voucher program; Study data lift ‘overhang’ on Insmed shares https://t.co/BCRJAUwGIJ $INSM + 7% $SRPT $SNY $GSK #biotech

By Ben Fidler
Women’s Health Holds $600B+ Opportunity by 2030
SocialMar 23, 2026

Women’s Health Holds $600B+ Opportunity by 2030

The data is finally catching up: $600B+ opportunity by 2030. Women’s health remains one of the most asymmetric opportunities in healthcare—where the next generation of category-defining companies like @mavenclinic will be built. https://t.co/K9nUGweSDK

By Deena Shakir
Pfizer's Lyme Vaccine Data Remains Ambiguous, FDA Review Looms
SocialMar 23, 2026

Pfizer's Lyme Vaccine Data Remains Ambiguous, FDA Review Looms

As someone who lived in Vermont and still spends the summer there, it's disappointing to see the ambiguity in Pfizer's data on a new Lyme disease vaccine. It's a serious threat. Now we can move on to speculating on the...

By John Carroll
Fecal pH May Predict Neurodegenerative Disease Risk
SocialMar 23, 2026

Fecal pH May Predict Neurodegenerative Disease Risk

I've been saying this for the longest time, and including fecal pH in my grant applications, too I predict that we'll see a significant correlation for fecal pH with neurodegenerative diseases in future papers...

By Michael Lustgarten, PhD
FDA OKs Fecal Transplants, Yet Access Declines
SocialMar 23, 2026

FDA OKs Fecal Transplants, Yet Access Declines

Paradox: The FDA approved some fecal transplants for C. difficile. But accessing treatment got harder. https://t.co/AFFyCGPeKW

By Matthew Herper
Phase 3 Lyme Vaccine Shows Mixed Preliminary Results
SocialMar 23, 2026

Phase 3 Lyme Vaccine Shows Mixed Preliminary Results

The news is mixed in the preliminary results from a Phase 3 trial of a needed #Lyme disease vaccine, @matthewherper reports. https://t.co/bcbfeXchk1

By Helen Branswell
Lyme Vaccine Hits 70% Efficacy, Misses Confidence Threshold
SocialMar 23, 2026

Lyme Vaccine Hits 70% Efficacy, Misses Confidence Threshold

The $PFE/ $VALN Lyme vaccine was a product for which there was a lot of hope. Results today show OK efficacy. Vaccine efficacy landed at 70%; investors hoped for 80% but thought as low as 60% would be relevant. But the...

By Matthew Herper
Healthcare Drives Job Growth, Outpacing National Gains
SocialMar 23, 2026

Healthcare Drives Job Growth, Outpacing National Gains

"Over the past year, the U.S. has added 156,000 jobs—but healthcare alone was responsible for 375,000 new jobs." https://t.co/85IevT4vGd

By Eddy Elfenbein
Child's C. Diff Cure Required a Grueling Fecal Transplant Journey
SocialMar 23, 2026

Child's C. Diff Cure Required a Grueling Fecal Transplant Journey

Her son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey https://t.co/Ln54u1iTPV via @statnews

By Matthew Herper
New Guidelines Add Testing, Therapy for ESR1‑mutated Metastatic Breast Cancer
SocialMar 23, 2026

New Guidelines Add Testing, Therapy for ESR1‑mutated Metastatic Breast Cancer

Guideline Update Provides New Testing & Tx Recx for Pts w/ ER-Positive, HER2-Negative Met Breast Cancer w/ ESR1 Mutations [May 17-18, 2023] @ASCO Daily News - https://t.co/3ZVrEkQEN5 @DrHBurstein et al. @JCO_ASCO https://t.co/68e7D0CSgU #bcsm #PrecisionMedicine #LiquidBiopsy https://t.co/KBx2hq2BDW

By Mike Thompson, MD PhD
Low‑
SocialMar 23, 2026

Low‑

Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dexamethasone (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol https://t.co/hXxlFINejC #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm https://t.co/3Pa2TRMntk

By Mike Thompson, MD PhD
Personalized Therapy Improves Outcomes in Residual TNBC
SocialMar 23, 2026

Personalized Therapy Improves Outcomes in Residual TNBC

BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer [Dec 15, 2021] Schneider et al. Radovich @JCO_ASCO https://t.co/oJm6BJrMtA #bcsm #PrecisionMedicine

By Mike Thompson, MD PhD
Genetic Links to Aromatase Inhibitor Musculoskeletal Side Effects
SocialMar 23, 2026

Genetic Links to Aromatase Inhibitor Musculoskeletal Side Effects

Genome-Wide Associations [GWAS] and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors [Sep 20, 2010] Ingle et al. @DrWeinshilboum @JCO_ASCO https://t.co/1NJcXkWy8c #bcsm #Supponc

By Mike Thompson, MD PhD
Circulating DNA/Cells Predict Recurrence Post‑Chemo in TNBC
SocialMar 23, 2026

Circulating DNA/Cells Predict Recurrence Post‑Chemo in TNBC

Assoc of Circulating Tumor DNA & Circulating Tumor Cells After Neoadjuvant Chemotherapy w/ Disease Recurrence in Pts w/ Triple-Negative Breast Cancer: BRE12-158 RCT [Jul 9, 2020] Radovich et al. @JAMAOnc https://t.co/XxH9kTT9d5 #bcsm #cactc #NCT02101385 https://t.co/kgV0yM2I1f

By Mike Thompson, MD PhD
Pfizer's Lyme Phase 3 Cut by One‑Third Over Contractor Issues
SocialMar 23, 2026

Pfizer's Lyme Phase 3 Cut by One‑Third Over Contractor Issues

Pfizer's phase 3 for its Lyme trial was supposed to be 18k patients -- but issues with a contractor at the start of the trial cut the size by a third, and @ky_lahucik + I reported a long time ago...

By Drew Armstrong
P7C3 Boosts NAD Enzyme, Improves Mouse Alzheimer Model
SocialMar 23, 2026

P7C3 Boosts NAD Enzyme, Improves Mouse Alzheimer Model

P7C3 is an activator of an enzyme that makes NAD called NAMPT. Cool that it’s working in a 🐁 model of AD 👏

By David Sinclair, PhD
Under‑50 Bowel Cancer Cases Surge Globally, Linked to Lifestyle
SocialMar 23, 2026

Under‑50 Bowel Cancer Cases Surge Globally, Linked to Lifestyle

A study published in #TheLancet Oncology reports a rise in bowel #cancer cases among people under 50 in 27 out of 50 countries over 10 years. Possible causes include obesity, gut bacteria, ultra-processed foods, and ... #healthcare #research https://t.co/Mjap7D8jtb

By Catherine Adenle
Pfizer Lyme Vaccine Effective yet Misses Crucial Statistical Benchmark
SocialMar 23, 2026

Pfizer Lyme Vaccine Effective yet Misses Crucial Statistical Benchmark

Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle There is a set up for drama here. $Valn $pfe Valneva stock is down 14% in premarket trading. https://t.co/WN0KOl4Nqh via @statnews

By Matthew Herper
Frontline Nurses Demand Safety Amid Collapsing ER System
SocialMar 23, 2026

Frontline Nurses Demand Safety Amid Collapsing ER System

Healthcare is the only industry where you can be assaulted on the job and still be expected to finish your shift. Emergency nurse Kristen Cline has spent 20 years on the front lines. In a recent conversation on The Podcast by...

By Kevin Pho, MD
Robots Handle Routine Tasks, Not Replace Surgeons
SocialMar 23, 2026

Robots Handle Routine Tasks, Not Replace Surgeons

Developing humanoid robots to help with mundane tasks such as sterilizing surgical devices all day is one thing. But saying these robots could "help in the operating room" sends the wrong message that they might replace surgeons, which couldn't be...

By Bertalan Meskó, PhD
Chinese Hospital's Blood‑Drawing Robot Hits 94.3% Success
SocialMar 23, 2026

Chinese Hospital's Blood‑Drawing Robot Hits 94.3% Success

Chinese Hospital Deploys Blood-Drawing #Robot Achieving a 94.3% Success Rate by @Khulood_Almani #Robotics #MachineLearning #ArtificialIntelligence #ML https://t.co/ngECMoad52

By Ron van Loon
Stem Cell Dose Boosts Walk Test, Cuts Frailty
SocialMar 23, 2026

Stem Cell Dose Boosts Walk Test, Cuts Frailty

Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty 🌟Performance on the 6-minute walk test improved in a dose-response fashion 🌟Improved 6-minute walk test distance correlated with patient-reported outcomes 🌟The percentage of study subjects classified as frail decreased...

By David Barzilai, MD PhD
Dismissed Symptoms Harm; Treat Mental Health Equally
SocialMar 23, 2026

Dismissed Symptoms Harm; Treat Mental Health Equally

Provider dismissal of medical symptoms does so much harm, including and perhaps especially folks whose symptoms are related to mental health. Migraines caused by stress are still painful, debilitating, and need to be treated. If medical providers want people to address the...

By Dr. Jessica Goodnight
Single Stem Cell Dose Boosts Strength, Reverses Frailty
SocialMar 22, 2026

Single Stem Cell Dose Boosts Strength, Reverses Frailty

Stem cell therapy shows promise for reversing aging-related frailty in new clinical trial 🗣️A clinical trial reports that a single dose can significantly improve physical strength and key signs of aging in older adults with frailty. https://t.co/5mw5r64imb https://t.co/uI88QpTEIa

By David Barzilai, MD PhD
FDA Staff Hear Peptide Plan via Rogan Podcast
SocialMar 22, 2026

FDA Staff Hear Peptide Plan via Rogan Podcast

“At least two career staffers at the FDA whose work includes compounding drugs said they learned of the health secretary’s plans to take action on peptides only from his appearance on Rogan’s podcast.” https://t.co/vpTDqstpDZ

By Bijan Salehizedah
OpenEvidence Turns Societies Into Evidence Creators, Securing AI CDS Moat
SocialMar 22, 2026

OpenEvidence Turns Societies Into Evidence Creators, Securing AI CDS Moat

OpenEvidence started as the place clinicians go to find clinical evidence. Now they're becoming the place medical societies go to CREATE it - that's a whole new moat for winning the AI CDS market. My 5 thoughts... First, the gist of...

By Joshua Liu, MD
Allogeneic Stem Cells Safely Boost Function in Frail Adults
SocialMar 22, 2026

Allogeneic Stem Cells Safely Boost Function in Frail Adults

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial “Treated groups had remarkable improvements in physical performance measures and inflammatory biomarkers, both of which characterize the frailty syndrome. Given the excellent safety and efficacy...

By David Barzilai, MD PhD
Whiteboard Tactics Unlock NHS Negotiation Success
SocialMar 22, 2026

Whiteboard Tactics Unlock NHS Negotiation Success

The Whiteboard Windfall: A Lesson in NHS Negotiations by @Timothy_Hughes https://t.co/2JqnBxsbKP @DLAIgnite #SocialSelling #DigitalSelling #Sales #SalesTips #SalesLeader #Salesforce #SalesEnablement #RevOps #Leadership #Marketing #SalesNegotiation https://t.co/QfAUP3Lf1B

By Tim Hughes
Lifestyle Program Slows Aging and Boosts Function in Frail Seniors
SocialMar 22, 2026

Lifestyle Program Slows Aging and Boosts Function in Frail Seniors

A Multidomain Lifestyle Intervention Is Associated With Improved Functional Trajectories and Favorable Changes in Epigenetic Aging Markers in Frail Older Adults: A Randomized Controlled Trial https://t.co/8Ex1caVyLp

By David Barzilai, MD PhD
Hackathon Targets Neural Repair, AI Surgery, Cryo Innovations
SocialMar 22, 2026

Hackathon Targets Neural Repair, AI Surgery, Cryo Innovations

DEFEATING ENTROPY hackathon at @fiftyyears London HQ. Focus areas: Biomaterials for neural repair Engineered neural cells Tissue replacement AI for surgical robotics Advanced cryo methods Biostasis https://t.co/gMDDoo6Io4

By Seth Bannon
Higher Thymic Health Scores Predict Longer Healthspan
SocialMar 22, 2026

Higher Thymic Health Scores Predict Longer Healthspan

Your Thymus and Your Healthspan https://t.co/ENhIn2A2l3 High vs Low Thymic Health Scores and Outcomes https://t.co/oOz9sOK8RV

By Eric Topol
Muscle Power Predicts Mortality Far Better than Strength
SocialMar 22, 2026

Muscle Power Predicts Mortality Far Better than Strength

Wow... Power training and longevity Araújo et al. followed 3,899 people — mostly middle-aged and older adults — for a median of nearly 11 years. They compared two metrics head-to-head: muscle strength and muscle power. Men in the lowest power category were...

By Howard Luks, MD
No‑Code AI App Calculates TAVR Valve Sizing Instantly
SocialMar 22, 2026

No‑Code AI App Calculates TAVR Valve Sizing Instantly

Please write the app that tells me how long 2 TAVRs will last if the first is installed in me soon....

By Matthew Holt
Blueprint for Building a $15B J&J Acquisition Target
SocialMar 22, 2026

Blueprint for Building a $15B J&J Acquisition Target

How do you build a company that $JNJ will buy for $15 billion? Listen here.

By Matthew Herper
FHIR Interoperability Accelerates with New APIs and Docs
SocialMar 22, 2026

FHIR Interoperability Accelerates with New APIs and Docs

It's important to celebrate the interoperability wins just as often as leaning in on all the drama. To that extent, let's start the clap as @eClinicalWorks just dropped 9 new FHIR APIs, including full CRUD on Coverage and e-prescribing data...

By Brendan Keeler
Every 1% BMI Drop Lowers Cancer Risk
SocialMar 22, 2026

Every 1% BMI Drop Lowers Cancer Risk

Every 1% BMI Drop Cuts Cancer Risk Every 1% drop in BMI lowers your cancer risk. The data now proves it in the real world. As a medical school professor, I have taught for years that obesity drives cancer through metabolic dysfunction....

By Robert Lufkin, MD
Quantum Computers Poised to Tackle Healthcare Challenges Soon
SocialMar 22, 2026

Quantum Computers Poised to Tackle Healthcare Challenges Soon

Can quantum computers now solve health care problems? We'll soon find out. | MIT Technology Review https://t.co/fQ3aSQxhdd

By Chuck Brooks